Number of the records: 1  

Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.

  1. TitleSulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.
    Author Pastorek Michal SAVEXONK ; SAVMOMEC - Ústav experimentálnej onkológie SAV    RID    ORCID
    Co-authors Šimko Veronika 1985 SAVVIR - Virologický ústav SAV

    Takáčová Martina 1981 SAVVIR ; SAVMOMEC - Virologický ústav SAV

    Baráthová Monika 1976- SAVVIR ; SAVMOMEC - Virologický ústav SAV    ORCID

    Bartošová Mária 1974 SAVVIR - Virologický ústav SAV    ORCID

    Hunáková Ľuba 1967- SAVEXONK - Ústav experimentálnej onkológie SAV    ORCID

    Sedláková Oľga 1957 SAVVIR - Virologický ústav SAV

    Hudecová Soňa 1956- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV

    Križanová Oľga 1960- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV    ORCID

    Dequiedt F.

    Pastoreková Silvia 1961 SAVVIR - Virologický ústav SAV    ORCID

    Sedlák Ján 1957- SAVEXONK - Ústav experimentálnej onkológie SAV

    Source document International Journal of Oncology. Vol. 47, no. 1 (2015), p. 51-60
    Languageeng - English
    CountryGR - Greece
    Document kindrozpis článkov z periodík (rbx)
    CitationsZHANG, Zhen - LI, Chunliu - SHANG, Li - ZHANG, Yuejuan - ZOU, Rong - ZHAN, Yan - BI, Benjun. Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells. In SPRINGERPLUS. ISSN 2193-1801, 2016, vol. 5, no., pp.
    PAL, Sanjima - KONKIMALLA, V. Badireenath. Hormetic Potential of Sulforaphane (SFN) in Switching Cells' Fate Towards Survival or Death. In MINI-REVIEWS IN MEDICINAL CHEMISTRY. ISSN 1389-5575, 2016, vol. 16, no. 12, pp. 980.
    TIAN, Hua - ZHOU, Yan - YANG, Gaoxiang - GENG, Yang - WU, Sai - HU, Yabin - LIN, Kai - WU, Wei. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells. In ONCOLOGY REPORTS. ISSN 1021-335X, 2016, vol. 36, no. 3, pp. 1361.
    JUENGEL, Eva - MAXEINER, Sebastian - RUTZ, Jochen - JUSTIN, Saira - ROOS, Frederik - KHODER, Wael - TSAUR, Igor - NELSON, Karen - BECHSTEIN, Wolf O. - HAFERKAMP, Axel - BLAHETA, Roman A. Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro. In ONCOTARGET. ISSN 1949-2553, 2016, vol. 7, no. 51, pp. 85208-85219.
    PISTOLLATO, Francesca - CALDERON IGLESIAS, Ruben - RUIZ, Roberto - APARICIO, Silvia - CRESPO, Jorge - DZUL LOPEZ, Luis - GIAMPIERI, Francesca - BATTINO, Maurizio. The use of natural compounds for the targeting and chemoprevention of ovarian cancer. In CANCER LETTERS. ISSN 0304-3835, 2017, vol. 411, no., pp. 191-200.
    MOKHTARI, Reza Bayat - HOMAYOUNI, Tina S. - BALUCH, Narges - MORGATSKAYA, Evgeniya - KUMAR, Sushil - DAS, Bikul - YEGER, Herman. Combination therapy in combating cancer. In ONCOTARGET. ISSN 1949-2553, 2017, vol. 8, no. 23, pp. 38022-38043.
    JUENGEL, Eva - EULER, Stephanie - MAXEINER, Sebastian - RUTZ, Jochen - JUSTIN, Saira - ROOS, Frederik - KHODER, Wael - NELSON, Karen - BECHSTEIN, Wolf O. - BLAHETA, Roman A. Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines. In PHYTOMEDICINE. ISSN 0944-7113, 2017, vol. 27, no., pp. 1-7.
    SHUKLA, Gaurav - KHERA, Harvinder Kour - SRIVASTAVA, Amit Kumar - KHARE, Piush - PATIDAR, Rahul - SAXENA, Rajiv. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review. In CURRENT STEM CELL RESEARCH & THERAPY. ISSN 1574-888X, 2017, vol. 12, no. 3, pp. 207-224.
    NEGRETTE-GUZMAN, Mario - HUERTA-YEPEZ, Sara - VEGA, Mario I. - CARLOS LEON-CONTRERAS, Juan - HERNANDEZ-PANDO, Rogelio - NOEL MEDINA-CAMPOS, Omar - RODRIGUEZ, Esteban - TAPIA, Edilia - PEDRAZA-CHAVERRI, Jose. Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells. In FOOD AND CHEMICAL TOXICOLOGY. ISSN 0278-6915, 2017, vol. 100, no., pp. 90-102.
    SITA, Giulia - HRELIA, Patrizia - GRAZIOSI, Agnese - MORRONI, Fabiana. Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment. In NUTRIENTS. ISSN 2072-6643, 2018, vol. 10, no. 11, pp.
    SU, Xuling - JIANG, Xin - MENG, Lingbin - DONG, Xiaoming - SHEN, Yanjun - XIN, Ying. Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway. In OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. ISSN 1942-0900, 2018, vol., no., pp.
    RUSSO, Maria - SPAGNUOLO, Carmela - RUSSO, Gian Luigi - SKALICKA-WOZNIAK, Krystyna - DAGLIA, Maria - SOBARZO-SANCHEZ, Eduardo - NABAVI, Seyed Fazel - NABAVI, Seyed Mohammad. Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment. In CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION. ISSN 1040-8398, 2018, vol. 58, no. 8, pp. 1391-1405.
    KATHAWALA, Rishil J. - KUDELKA, Andrzej - RIGAS, Basil. The Chemoprevention of Ovarian Cancer: the Need and the Options. In Current Pharmacology Reports, 2018-06-01, 4, 3, pp. 250-260.
    MOKHTARI, Reza Bayat - BALUCH, Narges - MORGATSKAYA, Evgeniya - KUMAR, Sushil - SPARANEO, Angelo - MUSCARELLA, Lucia Anna - ZHAO, Sheyun - CHENG, Hai-Ling - DAS, Bikul - YEGER, Herman. Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. In BMC CANCER, 2019, vol. 19, no. 1, pp.
    NEGRETTE-GUZMAN, Mario. Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy. In EUROPEAN JOURNAL OF PHARMACOLOGY. ISSN 0014-2999, 2019, vol. 859, no., pp.
    ROY, Madhumita - DATTA, Amitava. Improvement of Cancer Therapy Using Phytochemicals. In CANCER GENETICS AND THERAPEUTICS: FOCUS ON PHYTOCHEMICALS, 2019, vol., no., pp. 139-164. Dostupné na: https://doi.org/10.1007/978-981-13-9471-3_6.
    NALINI, Devarajan - SELVARAJ, Jayaraman - KUMAR, Ganesan Senthil. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia. In JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. ISSN 0171-5216, 2020, vol. 146, no. 1, pp. 1-18. Dostupné na: https://doi.org/10.1007/s00432-019-03068-x.
    MANDRICH, Luigi - CAPUTO, Emilia. Brassicaceae-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer. In NUTRIENTS, 2020, vol. 12, no. 3, pp. Dostupné na: https://doi.org/10.3390/nu12030868.
    CALCABRINI, Cinzia - MAFFEI, Francesca - TURRINI, Eleonora - FIMOGNARI, Carmela. Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects. In FRONTIERS IN PHARMACOLOGY. ISSN 1663-9812, 2020, vol. 11, no., pp. Dostupné na: https://doi.org/10.3389/fphar.2020.00567.
    KLEMBA, Aleksandra - BODNAR, Lubomir - WAS, Halina - BRODACZEWSKA, Klaudia K. - WCISLO, Gabriel - SZCZYLIK, Cezary A. - KIEDA, Claudine. Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, vol. 21, no. 24, pp. Dostupné na: https://doi.org/10.3390/ijms21249492.
    PARK, In Sil - HAN, Youngjin - LEE, Ki Won - SONG, Yong Sang - CHO, Jae Hyun. Targeting cancer stem cells with phytoceuticals for cancer therapy. In Functional Foods in Cancer Prevention and Therapy, 2020-01-01, pp. 329-357. Dostupné na: https://doi.org/10.1016/B978-0-12-816151-7.00017-X.
    DEVARAJAN, Nalini - MANJUNATHAN, Reji - GANESAN, Senthil Kumar. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients. In CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. ISSN 1040-8428, 2021, vol. 162, no., pp. Dostupné na: https://doi.org/10.1016/j.critrevonc.2021.103327.
    ALI, Ali Hassan A. - ALMALKI, Abdulrahman M. - ALHARBI, Talal A. - ALANZY, Musaad H. - ALGHUWAINEM, Muath A. - ALANAZI, Fahd M. - ALSHUMAYMIRI, Nasser - MOHAMED, Aly Fahmy. Evaluation of anticancer activity of Paclitaxel (PLT) and D-L Sulfarophane (SFN) as natural vegetable derivative against colon cancer cell line: In vitro study. In MEDICAL SCIENCE. ISSN 2321-7359, 2021, vol. 25, no. 114, pp. 1900-1909.
    LI, Luanfeng - LIU, Wensi - TANG, Haichao - WANG, Xiangyi - LIU, Xinli - YU, Zhaojin - GAO, Yanan - WANG, Xiaobin - WEI, Minjie. Hypoxia-related prognostic model in bladder urothelial reflects immune cell infiltration. In AMERICAN JOURNAL OF CANCER RESEARCH, 2021, vol. 11, no. 10, pp. 5076-5093. ISSN 2156-6976.
    MA, Zhaowu - XIANG, Xiaoqiang - LI, Shiya - XIE, Peng - GONG, Quan - GOH, Boon-Cher - WANG, Lingzhi. Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds. In SEMINARS IN CANCER BIOLOGY, 2022, vol. 80, no., pp. 379-390. ISSN 1044-579X. Dostupné na: https://doi.org/10.1016/j.semcancer.2020.09.011.
    SCUTO, Maria - ONTARIO, Maria Laura - SALINARO, Angela Trovato - CALIGIURI, Isabella - RAMPULLA, Francesco - ZIMBONE, Vincenzo - MODAFFERI, Sergio - RIZZOLIO, Flavio - CANZONIERI, Vincenzo - CALABRESE, Edward J. - CALABRESE, Vittorio. Redox modulation by plant polyphenols targeting vitagenes for chemoprevention and therapy: Relevance to novel anti-cancer interventions and mini-brain organoid technology. In FREE RADICAL BIOLOGY AND MEDICINE, 2022, vol. 179, no., pp. 59-75. ISSN 0891-5849. Dostupné na: https://doi.org/10.1016/j.freeradbiomed.2021.12.267.
    MELIM, Catarina - MAGALHAES, Mariana - CLAUDIA SANTOS, Ana - JULIAO CAMPOS, Elisa - CABRAL, Celia. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. In EXPERT OPINION ON DRUG DELIVERY, 2022, vol. 19, no. 2, pp. 179-197. ISSN 1742-5247. Dostupné na: https://doi.org/10.1080/17425247.2022.2041599.
    SONG, Mengdi - CUI, Mingxiao - LIU, Kehai. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. In EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, vol. 232, no., pp. ISSN 0223-5234. Dostupné na: https://doi.org/10.1016/j.ejmech.2022.114205.
    ZHU, Y. - HU, Haijun - HUANG, K. - SUN, Xiao - LI, Mingwei. Sulforaphane Inhibits Proliferation and Apoptosis of Colorectal Cancer Cells by Down-Regulating the Cyclooxygenase-2/Protein Kinase B/Glycogen Synthase Kinase-3 Beta Signaling Pathway. In INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, vol. 84, no. 1, pp. 219-223. ISSN 0250-474X. Dostupné na: https://doi.org/10.36468/pharmaceutical-sciences.913.
    ZHANG, Z.K. - WU, B. - SHAO, Y. - CHEN, Y.Q. - WANG, D.W. A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer. In PLOS ONE. ISSN 1932-6203, DEC 21 2022, vol. 17, no. 12. Dostupné na: https://doi.org/10.1371/journal.pone.0278556.
    ZHANG, X. - CHEN, Y.Y. - LI, H.M. - CHEN, B.B. - LIU, Z.J. - WU, G. - LI, C.Y. - LI, R.Y. - CAO, Y. - ZHOU, J.Q. - SHEN, M. - LIU, H.L. - TAO, J.L. Sulforaphane Acts Through NFE2L2 to Prevent Hypoxia-Induced Apoptosis in Porcine Granulosa Cells via Activating Antioxidant Defenses and Mitophagy. In JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. ISSN 0021-8561, 2022 JUN 21 2022. Dostupné na: https://doi.org/10.1021/acs.jafc.2c01978.
    JOSHI, E. - PANDYA, M. - DESAI, U. Current Drugs and their Therapeutic Targets for Hypoxia-inducible Factors in Cancer. In CURRENT PROTEIN & PEPTIDE SCIENCE. ISSN 1389-2037, 2023, vol. 24, no. 6, p. 447-464. Dostupné na: https://doi.org/10.2174/1389203724666230601092245.
    ISLAM, M.R. - RAHMAN, M.M. - DHAR, P.S. - NOWRIN, F.T. - SULTANA, N. - AKTER, M. - RAUF, A. - KHALIL, A.A. - GIANONCELLI, A. - RIBAUDO, G. The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives. In MOLECULES. MAR 2023, vol. 28, no. 5. Dostupné na: https://doi.org/10.3390/molecules28052070.
    SHOAIB, S. - KHAN, F.B. - ALSHARIF, M.A. - MALIK, M.S. - AHMED, S.A. - JAMOUS, Y.F. - UDDIN, S. - TAN, C.S. - ARDIANTO, C. - TUFAIL, S. - MING, L.C. - YUSUF, N. - ISLAM, N. Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. In CANCERS. APR 2023, vol. 15, no. 8. Dostupné na: https://doi.org/10.3390/cancers15082390.
    WANG, K.X. - LI, Y.H. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. In FRONTIERS IN ENDOCRINOLOGY. ISSN 1664-2392, OCT 19 2023, vol. 14. Dostupné na: https://doi.org/10.3389/fendo.2023.1191759.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2015
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.3892/ijo.2015.2987
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201520143.025Q21.262Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.